This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.
Canada’s Pharmaceutical Products Industry: Canadian Industrial Profile Winter2009
Canada’s Pharmaceutical Products Industry: Canadian Industrial Profile Winter2009
Industry Economic Analysis
$550.00
- U.S. Recession—Although health-care spending is defensive, uninsured and unemployed people will spend less on drugs. With half of production destined for the U.S., the industry will be affected.
- Price Controls—Medications that are still under patent protection are subject to price controls in Canada. This has contributed to surging exports to the U.S.— but has also limited price and profit growth.
- Aging Population—People spend more on pharmaceutical products as they age. Thus, as the average age of the population increases, so does per capita spending on drugs.
Customers Who Downloaded This Also Liked
10 min read
9 min read
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
